Literature DB >> 29605292

Parallel reaction monitoring on a Q Exactive mass spectrometer increases reproducibility of phosphopeptide detection in bacterial phosphoproteomics measurements.

Christoph Taumer1, Lena Griesbaum1, Alen Kovacevic1, Boumediene Soufi1, Nicolas C Nalpas1, Boris Macek2.   

Abstract

Increasing number of studies report the relevance of protein Ser/Thr/Tyr phosphorylation in bacterial physiology, yet the analysis of this type of modification in bacteria still presents a considerable challenge. Unlike in eukaryotes, where tens of thousands of phosphorylation events likely occupy more than two thirds of the proteome, the abundance of protein phosphorylation is much lower in bacteria. Even the state-of-the-art phosphopeptide enrichment protocols fail to remove the high background of abundant unmodified peptides, leading to low signal intensity and undersampling of phosphopeptide precursor ions in consecutive data-dependent MS runs. Consequently, large-scale bacterial phosphoproteomic datasets often suffer from poor reproducibility and a high number of missing values. Here we explore the application of parallel reaction monitoring (PRM) on a Q Exactive mass spectrometer in bacterial phosphoproteome analysis, focusing especially on run-to-run sampling reproducibility. In multiple measurements of identical phosphopeptide-enriched samples, we show that PRM outperforms data-dependent acquisition (DDA) in terms of detection frequency, reaching almost complete sampling efficiency, compared to 20% in DDA. We observe a similar trend over multiple heterogeneous phosphopeptide-enriched samples and conclude that PRM shows a great promise in bacterial phosphoproteomics analyses where reproducible detection and quantification of a relatively small set of phosphopeptides is desired. SIGNIFICANCE: Bacterial phosphorylated peptides occur in low abundance compared to their unmodified counterparts, and are therefore rarely reproducibly detected in shotgun (DDA) proteomics measurements. Here we show that parallel reaction monitoring complements DDA analyses and makes detection of known, targeted phosphopeptides more reproducible. This will be of significance in replicated MS measurements that have a goal to reproducibly detect and quantify phosphopeptides of interest.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Escherichia coli; Orbitrap; Parallel reaction monitoring; Phosphoproteome; Targeted MS

Mesh:

Substances:

Year:  2018        PMID: 29605292     DOI: 10.1016/j.jprot.2018.03.028

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  5 in total

1.  A Strategy for Rapid Discovery of Marker Peptides Associated with Fibrinolytic Efficacy of Pheretima aspergillum Based on Bioinformatics Combined with Parallel Reaction Monitoring.

Authors:  Ting-Ting Feng; Jing-Xian Zhang; Yong-Peng Zhang; Jian Sun; Hong Yu; Xiang Tao; Xiu-Hong Mao; Qing Hu; Shen Ji
Journal:  Molecules       Date:  2022-04-20       Impact factor: 4.927

Review 2.  Phosphoproteomic Approaches to Discover Novel Substrates of Mycobacterial Ser/Thr Protein Kinases.

Authors:  Seanantha S Baros; Jonathan M Blackburn; Nelson C Soares
Journal:  Mol Cell Proteomics       Date:  2019-12-15       Impact factor: 5.911

3.  Import of extracellular ATP in yeast and man modulates AMPK and TORC1 signalling.

Authors:  Gabriella M Forte; Elizabeth Davie; Shervi Lie; Mirita Franz-Wachtel; Ashley J Ovens; Tingting Wang; Jonathan S Oakhill; Boris Maček; Iain M Hagan; Janni Petersen
Journal:  J Cell Sci       Date:  2019-04-03       Impact factor: 5.285

4.  Proteomic analysis of Aspergillus niger 3.316 under heat stress.

Authors:  Xiangyu Deng; Bin Du; Fengmei Zhu; Yanan Gao; Jun Li
Journal:  Microbiologyopen       Date:  2020-02-27       Impact factor: 3.139

Review 5.  Advanced Proteomics as a Powerful Tool for Studying Toxins of Human Bacterial Pathogens.

Authors:  Catherine Duport; Béatrice Alpha-Bazin; And Jean Armengaud
Journal:  Toxins (Basel)       Date:  2019-10-04       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.